Cite
HARVARD Citation
Kolovou, V. et al. (2021). Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia: A One Center Study. Journal of cardiovascular pharmacology and therapeutics. pp. 51-58. [Online].